Krosslinker
Entrepreneur First '19Singapore, SG · Founded 2019 · 15 employees on LinkedIn · 5 known investors
Find your way into Krosslinker
335 people in our graph share verified history with the Krosslinker team — schools, employers, funds. One of them is your warm intro.
Krosslinker develops aerogel-based materials for thermal insulation, including cooling paints, composite boards, and silica aerogel powders. Its products target industrial and building applications requiring lightweight, high-performance insulation.
Also known as KrossLinker · Krosslinker Pte Ltd
Founders & leadership
Krosslinker was founded in 2019 by Gayathri Natarajan, Elmira Soghrati, and Mahesh Nathan.


Investors · 5
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$1.3M disclosed across 1 round · 2020
- $1.3Mseed fundingNov 2020 · 2 sources
500 Startups (lead), 500 Startups' South-east Asia-focused 500 Durians fund (lead), Entrepreneur First, SEEDS Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026KrossLinker is a Singapore-based deep-tech advanced materials company that designs and manufactures silica aerogels for thermal insulation. It describes silica aerogel as the most insulating solid material and states that its proprietary, scalable technology platform makes aerogels more affordable, durable and versatile, enabling adoption in paints and coatings, cold-chain logistics and industrial insulation.
The company's product line includes KrossShield SR Pro™, an aerogel-based cooling paint aimed at urban heat reduction and building energy saving; Cryar®, a super-insulating aerogel composite board; QuintAero®, an ultra-light, low-conductivity silica aerogel powder; and flexible aerogel composite blankets described as in development. Cryar® is presented as a water-based, eco-friendly silica aerogel composite board made through an energy-efficient process, targeted at transporting temperature-sensitive pharmaceutical products such as drugs, vaccines and clinical trial samples, and characterized as non-toxic, lightweight and reusable with long-term property stability.
KrossLinker frames its core technical claim around manufacturing economics: the company states that its aerogel is produced at roughly half the production and capital expenditure of traditional aerogel without performance loss, achieved through faster production and a low-energy novel drying technology, and that this was demonstrated on its pilot production line.
Founding story
KrossLinker was founded in 2019 by a team of scientists holding doctorates: Dr. Elmira Soghrati, Dr. Gayathri Natarajan and Dr. Mahesh Sachithanadam. Natarajan has said the underlying silica aerogel production technology came out of several years of research aimed at addressing the cost, energy and scalability roadblocks of traditional aerogel manufacturing.
Business model
KrossLinker develops and manufactures aerogel materials and finished insulation products (boards, powders, coatings and, in development, blankets) that it sells or co-develops with partners in downstream sectors such as specialty packaging, logistics and construction. The company describes a proprietary production platform (ASPIRE®) intended to lower manufacturing and capital costs relative to conventional aerogel processes, positioning cost reduction as the basis of its commercial offer. As of early 2023 it operated a pilot production line and was working with packaging firms, logistics providers and hospitals to commercialize its cold-chain product.
Sources indicate product sales of aerogel materials and insulation products (boards, powders, coatings) to industrial and packaging customers, plus co-development arrangements with partners; no pricing, contract structure or revenue figures are disclosed.
Traction
As of February 2023 the company had a pilot production line demonstrating its process, its first product (Cryar®) targeting cold chain, collaborations with packaging firms, logistics companies and hospitals, and a group of institutional and government-linked backers including Seeds Capital, ADB Ventures, She1k, Enterprise Singapore, Third Derivative, 500 Global and Entrepreneur First. No revenue, customer counts or shipment volumes are disclosed in the sources.
Latest developments
The company's website presents an expanded portfolio beyond the original cold-chain board, including the KrossShield SR Pro™ aerogel cooling paint for building and construction, the QuintAero® silica aerogel powder, and an aerogel blanket listed as in development, alongside two named application areas: building and construction, and cold-chain storage and transport. Leadership is currently listed as Dr. Gayathri Natarajan (Co-Founder & CEO) and Dr. Mahesh Sachithanandam (Co-Founder & CTO).
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
KrossLinker positions itself as a cost-disruptive entrant in the aerogel insulation market, aiming to move aerogel from a niche, expensive material into mainstream thermal insulation applications. Its initial target market is pharmaceutical cold-chain packaging, an industry the company cites as losing roughly USD 35 billion annually to temperature excursions, with packaging accounting for around 30% of pharmaceutical cold-chain companies' total spending according to a 2020 report cited by the company. No market share or competitive ranking data is available in the sources.
KrossLinker's stated differentiation is its patented aerogel platform technology, referred to as ASPIRE®, which an ADB Ventures investment specialist described as addressing the long R&D cycles, high capital expenditure and energy intensity of traditional aerogel manufacturing. The company claims production at about half the production and capital cost of conventional aerogel processes, together with a water-based, eco-friendly formulation, high-speed manufacturing, low-energy production, and the ability to produce aerogel in multiple physical forms (board, powder, coating, blanket).
Technology
KrossLinker's technology centers on silica aerogel produced via a patented platform the company and its investor describe as ASPIRE®. Key elements cited are a novel water-based chemistry and formulation, a low-energy novel drying technology, high-speed manufacturing, and the ability to produce aerogel in versatile forms. Product attributes claimed include best-in-class thermal insulation from the nano-porous silica aerogel structure, water resistance, fire retardancy, non-toxicity, light weight, reusability and long-term stability of properties.
Go-to-market
The company commercializes through collaborations and strategic partnerships rather than solely direct sales: it has worked with specialty packaging companies, logistics companies and hospitals to accelerate adoption of Cryar® aerogel shippers, and states it has been building partnerships with market leaders to co-develop aerogel products for adjacent verticals including e-mobility and energy infrastructure.
Pharmaceutical cold-chain and logistics operators shipping drugs, vaccines and clinical trial samples; specialty packaging providers; hospitals; food logistics; building and construction users seeking passive cooling coatings; and industrial insulation buyers, with stated interest in e-mobility and energy infrastructure verticals.
Geography
The company is headquartered and based in Singapore; sources do not describe operations in other locations.
History
The company was founded in 2019 in Singapore by three PhD scientists. By February 2023 it had developed its first product, Cryar® Aerogel Board, for the pharmaceutical cold chain, had demonstrated production on a pilot line, and had assembled an investor base that it listed as Seeds Capital, ADB Ventures, She1k, Enterprise Singapore, Third Derivative, 500 Global and Entrepreneur First; ADB Ventures had been an investor and partner since 2022. At that time the company announced it had opened a Series A round. Its current website lists a broader product portfolio including a cooling paint, an aerogel powder and a blanket product in development.
Risks & controversies
No controversies are reported in the available sources. Risks implied by the material include early commercial stage (pilot-scale production as of early 2023), dependence on partners for downstream commercialization, and unverified performance and cost claims that originate from the company and its investors.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsKrossLinker said it had just opened for Series A funding, seeking strategic investors to scale up commercial aerogel production for the cold-chain industry and expand R&D.
The company stated it had collaborated with several specialty packaging and logistics companies and hospitals to commercialize Cryar® aerogel shippers, and was building strategic partnerships to co-develop aerogel products for vertical markets such as e-mobility and energy infrastructure.
KrossLinker announced Cryar®, described as a first-of-its-kind water-based, eco-friendly silica aerogel composite board produced through an energy-efficient process, as its first aerogel product targeting the pharmaceutical cold-chain market. The company said it was producing on a pilot production line.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 6
primary sources listed
- Krosslinkerkrosslinker.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Krosslinker do?
- Singapore deep-tech materials startup making low-cost silica aerogels for cold-chain, coatings and industrial insulation.
- Who founded Krosslinker?
- Krosslinker was founded by Gayathri Natarajan, Elmira Soghrati, Mahesh Nathan in 2019.
- Who are Krosslinker's investors?
- Krosslinker's investors include 500 Global, ADB Ventures, Entrepreneur First, SEEDS Capital.
- How much funding has Krosslinker raised?
- Krosslinker has disclosed $1.3M raised across 1 round.
- Where is Krosslinker headquartered?
- Krosslinker is headquartered in Singapore, SG.


